Rhumbline Advisers raised its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 3.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 564,518 shares of the company's stock after buying an additional 18,237 shares during the quarter. Rhumbline Advisers owned approximately 0.33% of Option Care Health worth $13,097,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Westfield Capital Management Co. LP lifted its holdings in Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company's stock worth $203,204,000 after buying an additional 599,589 shares during the last quarter. Global Alpha Capital Management Ltd. increased its holdings in Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company's stock valued at $1,559,000 after acquiring an additional 25,905 shares in the last quarter. Graypoint LLC purchased a new stake in shares of Option Care Health during the fourth quarter worth about $1,161,000. Victory Capital Management Inc. grew its holdings in Option Care Health by 4,432.8% in the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company's stock valued at $50,756,000 after buying an additional 1,585,818 shares during the period. Finally, Barclays PLC boosted its holdings in Option Care Health by 180.1% in the third quarter. Barclays PLC now owns 310,194 shares of the company's stock valued at $9,708,000 after acquiring an additional 199,454 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
OPCH has been the topic of several recent analyst reports. The Goldman Sachs Group cut Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. JMP Securities reiterated a "market outperform" rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. UBS Group assumed coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price target for the company. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and raised their price target for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, Barrington Research upped their price target on shares of Option Care Health from $32.00 to $33.00 and gave the company an "outperform" rating in a report on Tuesday, January 14th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $32.25.
Get Our Latest Stock Analysis on OPCH
Option Care Health Price Performance
Shares of OPCH traded up $0.31 during mid-day trading on Wednesday, reaching $32.94. 1,555,269 shares of the stock traded hands, compared to its average volume of 1,737,712. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $34.17. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a market cap of $5.60 billion, a price-to-earnings ratio of 27.65, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The firm has a fifty day moving average price of $28.07 and a 200 day moving average price of $28.00.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.02. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. As a group, equities research analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
